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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S291designer series describes ten year survival rates of up to 98%, with no
failures due to polyethylene wear or aseptic loosening of the tibial
component.
However, some smaller non-designer series have failed to replicate these
results. Recent commentaries on registry data have added to the debate
and there is still some confusion as to the true outcome of this procedure. It
has been suggested that both the centre and the individual surgeons
experience are critical is achieving good results. As yet no previous authors
have presented the results of trainees with this prosthesis. Traineesmay be
expected to achieve worse results with a technique that is highly surgeon
dependent.
The aim of this study is to present the survival of a large consecutive cohort
of medial OUKA performed in a specialist centre, bymultiple non-designer
surgeons, with the majority performed by trainees.
Methods: 1085 consecutive primary medial OUKA in 944 patients per-
formed between 1998 and 2008 were identiﬁed at a tertiary centre of
excellence from operative records. In each case the operation was per-
formed by a lower limb arthroplasty surgeon outside the designer team.
Operations performed by both trainee and consultant surgeons were
included. Failure was deﬁned as need for revision of any of the prosthetic
components for any cause and identiﬁed from hospital records, repeat
postal questionnaire to all patients and telephone follow-up of non-
responders. Family Doctor records were consulted in patients who
remained uncontactable. In patients who had died the Family Doctor was
contacted to determine the status of the knee at time of death. Survivor-
ship analysis was by construction of life table and cumulative survival
calculation. Results were stratiﬁed by grade of surgeon and level of
supervision.
Results: 1085 patients with an average age of 67yrs (SD 6.9) at time of
operation were identiﬁed. 681 (62.8%) knees were inserted by over 50
different trainees, 404 (37.2%) by 9 different consultants. At 10 years, 9
(0.83%) patients were lost to follow up and 76 (7%) had died. 46 knees
underwent revision surgery; 34 were revised to total knee arthroplasty
(TKA), 3 had revision of tibial or femoral component, 5 had additional
lateral unicompartmental knee arthroplasty for lateral compartment
progression of arthritis, and 4 underwent bearing change for dislocation or
impingement. The best case survival for the Oxford Medial Uni-
compartmental Knee Arthroplasty was 91% at 10 years. There was no
difference in the survival rates between consultants or registrars (p¼0.47).
If the Consultant was not in theatre at the time of the operation, registrars
achieved a 95% 10 year survival. The presence of the Consultant in theatre
with the trainee reduces survival to 82% at 10 years.
Conclusions: This is the largest single centre non designer series of Oxford
Unicompartmental Knee Arthroplasty ever reported and it demonstrates
excellent survival at 10 years. Over 60 surgeons were involved and there
was no difference in terms of survival between trainee and consultant
surgeons. These excellent results may include well established patient
selection criteria, thorough training programs and close expert supervision
of trainees who are not left to operate unsupervised until thoroughly
competent. Surprisingly, the presence of a consultant supervising a trainee
at the time of the operation led to a reduced 10 year survival. This may be
due to the fact that only fully trained competent registrars are left to
operate unsupervised and more junior and therefore less proﬁcient
trainees are those who are more closely supervised.
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EFFECT OF PREOPERATIVE WEIGHT LOSS ON POSTOPERATIVE
OUTCOMES AFTER HIGH TIBIAL OSTEOTOMY IN PATIENTS WITH
OBESITY, VARUS ALIGNMENT AND MEDIAL COMPARTMENT KNEE OA
A. Boulougouris 1, T.B. Birmingham 1, T.D. Olver 2, K.M. Leitch 1,
P. Lemon 2, J.R. Gifﬁn 1. 1Wolf Orthopaedic Biomechanics Lab., Univ. of
Western Ontario, London, ON, Canada; 2 Exercise Nutrition and Res. Lab.,
Univ. of Western Ontario, London, ON, Canada
Purpose: Varus alignment and obesity are both risk factors for the
progression of medial compartment knee OA and are the targets of various
interventions. The purpose of the present study was to evaluate the effect
of preoperative weight loss on knee-related outcome measures after
medial opening wedge high tibial osteotomy (HTO) for patients with
obesity, varus alignment and medial compartment knee OA. Wehypothesized that decreases in bodyweight preoperatively would result in
better knee-related outcomes 6 months postoperatively.
Methods: A total of 16 patients participated in this prospective cohort
study with matched historical controls. Eight patients completed an 8-
week physiotherapy program (2days/week), supplemented with fat loss
and body composition seminars (1day/week). These patients were
matched to historical controls based on sex, age (within 5 years), BMI
(within 2 points), Kellgren and Lawrence grade in the medial compart-
ment, and Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain
Domain (within 10 points). Outcome measures included the following: 3D
gait analysis (external knee adduction moment and gait speed), all KOOS
domains, the Lower Extremity Functional Scale (LEFS) and the Short Form
12 (SF-12) health status questionnaire. Changes from baseline to 6 months
after surgery were compared between groups using paired t-tests.
Results: The mean weight-loss before surgery was 4.7 kg (95%CI: 2.7, 6.8
kg) for the weight-loss group. Their mean weight-gain 6 months after
surgery was 1.5 kg (95%CI: -0.6, 3.6 kg). At 6 months after surgery, weight
in the preoperative weight-loss group was signiﬁcantly lower than the
controls [mean difference (95%CI): -2.5 kg (-5.4 , -0.3 kg)]. Both groups
improved substantially on all outcomes after surgery. However, there were
no signiﬁcant differences between groups. Between-group mean differ-
ences (95%CI) in change scores were as follows (weight-loss group minus
control group): Peak knee adduction moment, -1.9 Nm (-16.1, 13.8 Nm);
gait speed, 0.07 m/sec (-0.09, 0.22 m/sec); KOOS Pain domain, -2.1 (-21.3,
17.2); LEFS, -3.6 (-19.7, 12.4); SF-12 physical component summary, 1.5 (-7.8,
10.7); SF-12 mental component summary, 1.8 (-7.6, 11.3).
Conclusions: Although the extremes of the 95% conﬁdence intervals do
not exclude potentially clinically important differences between groups,
the present results suggest that obese patients with medial compartment
knee OA who lose weight before medial opening wedge HTO do not have
signiﬁcantly better knee-related outcomes 6 months postoperatively than
similar patients who do not lose weight preoperatively.
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NOVEL CORTICOSTEROID-CONTAINING VISCOSUPPLEMENT
FORMULATION PREVENTS POTENTIAL STEROID-INDUCED ADVERSE
EFFECTS ON CARTILAGE PROTEOGLYCANS
D. Gravett 1, H. Aberman 2, T. Simons 2, P. He 1, H. Panchal 1. 1Carbylan
BioSurgery, Inc, Palo Alto, CA, USA; 2Applied Biological Concepts, Inc, Los
Alamitos, CA, USA
Purpose: Viscosupplements and corticosteroids are commonly used intra-
articularly to treat the pain associated with osteoarthritis of the knee.
Viscosupplements are effective for up to six months but often have a slow
onset (4-6 weeks) for pain relief. Corticosteroids provide rapid pain relief
but often fail to provide long-term relief. A novel viscosupplement,
Hydros-TA, was developed to provide both rapid and long lasting pain
relief for the treatment of pain associated with osteoarthritis. The visco-
supplement comprises a low dose (10 mg) corticosteroid, triamcinolone
acetonide (TA), that is physically trapped within a crosslinked hyaluronic
acid based hydrogel bead suspended in a hyaluronic acid solution
(Hydros). The biocompatibility of this novel viscosupplement was studied
following intra-articular injection into the knee (Stiﬂe) of a goat to
demonstrate that this combination product did not cause adverse effects
on the cartilage and local joint tissue.
Methods: Thirty-six (36) adult goats, 18 castrated males and 18 females
were used to evaluate the local and systemic biocompatibility of the intra-
articular injections of 5.0 ml of Test or Control Material with 6 animals (3
males/3 females) per group. The following 6 treatment groups were used:
(1) Saline, (2) Hydros (viscosupplement with no corticosteroid), (3)
Hydros-TA(10mg), (4) Hydros-TA(40mg), (5) TA(10mg) and (6) TA(40mg).
The TA doses were scaled to animal weight and joint size. The contralateral
knee served as an internal control for each animal. The local biocompati-
bility was evaluated by gross, quantitative and histological analysis of the
joint and synovial ﬂuid at 28 days and 84 days post injection. The Mankin
Scoring system was used to access the effects of the treatment groups on
the joint cartilage. Systemic biocompatibility was evaluated by analysis of
blood chemistry and body weight pre-injection and at the time of sacriﬁce
as well as by histological analysis of the major organs.
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showed that the viscosupplement without the TA, and the low and high
dose TA-containing viscosupplement did not result in any systemic
toxicity. The gross analysis of the joint and the synovial ﬂuid showed that
the viscosupplement, with and without the TA, did not result in any local
adverse reaction as determined by gross joint scores, synovial ﬂuid anal-
ysis and cell counts. The differential counts of cells within the synovial
ﬂuid showed that the viscosupplement, with and without the TA, was non-
inﬂammatory. Histological analysis showed that the popliteal lymph nodes
were non-reactive and that the product was well tolerated within the
synovium.
The Safranin O stain depletion score of the Mankin scores (Figure 1)
showed that incorporation of the TA into the hydrogel component of the
viscosupplement resulted in a greater preservation of the proteoglycans in
the joint cartilage as compared to an equivalent bolus dose of the TA. These
differences were statistically signiﬁcant for Hydros-TA(10) compared to
TA(10) at both 28 days and 84 days (p¼0.002 and p¼0.03 respectively) and
for the Hydros-TA(40) compared to TA(40) at 84 days (p¼0.02).
Conclusions: Hydros-TA is biocompatible at 28 days and 84 days following
intra-articular injection into the knee joint of a goat model. Hydros-TA
formulations demonstrated reduced adverse effects on the articular
cartilage as compared to a similar dose of a bolus injection of a TA
suspension. This study demonstrated that the Hydros-TA was safe for
initiating human clinical studies and that incorporation of the corticoste-
roid within the hydrogel component could potentially provide protection
of the cartilage.
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VISCOELASTIC PROPERTIES AND ELASTIC RECOVERY OF HYADD4
HYDROGEL COMPARED TO CROSSLINKED HA-BASED COMMERCIAL
VISCOSUPPLEMENTS
D. Galesso 1, I. Finelli 2, G. Paradossi 2, D. Renier 1. 1 Fidia Farmaceutici SpA,
Abano Terme (PD), Italy; 2 Tor Vergata” Univ., Rome, Italy
Purpose: Viscosupplementation with hyaluronan (HA)-based hydrogels is
used in clinical practice to reduce pain and improve joint function in
osteoarthritis (OA) patients. Rheological properties of intra-articular vis-
cosupplements are fundamental for the quality and duration of mechan-
ical performance. Most of the highly viscoelastic HA-based products are
obtained through crosslinking techniques, causing a strong increase of the
biopolymer molecular weight but raising new issues of biocompatibility
and safety in the clinical environment. HYADD4 (HA partial hex-
adecylamide, contained in Hymovis) is a novel partially hydrophobic
linear (i.e. not chemically crosslinked) HA derivative with lowmodiﬁcation
degree, forming a viscoelastic hydrogel with enhanced intra-articular
residence time and whose clinical safety and effectiveness as visco-
supplement has already been proved. The aim of this study is to compare
the rheological properties of the HYADD4 hydrogel and of somecommercially available crosslinked-HA based viscosupplements, focusing
on the rheological response following mechanical stresses.
Methods: A stress-controlled rheometer was used to study the mechanical
response of the samples in oscillatory shear and in steady shear experi-
ments at 25C. The dynamic viscosity (h) at 1 sec-1 shear rate was deter-
mined, while viscoelasticity was measured in the frequency (u) range of
10-3 to 10 Hz. The recovery of the mechanical properties after a shock was
investigated as a function of time in a single or repeated cycle by oscillatory
measurements at the constant frequency of 1 Hz after destruction of the
gel network. Resistance of the hydrogels to stress was also assessed by
measuring the viscoelastic moduli as a function of increasing stress at
constant frequency.
Results: The dynamic viscosity of the HYADD4 hydrogel is comparable to
that of Synvisc although the former is a linear HA derivative and the latter
is a crosslinked one. Durolane shows the highest viscosity in the same
conditions. Similarly, the viscoelastic moduli G’ and G” of HYADD4 and of
Synvisc are comparable, whereas Durolane is characterized by a higher
viscoelasticity. For all of the three products the elastic modulus G’ is higher
than the viscous modulus G” in almost the whole range of frequency
observed, thus conﬁrming the “gel” character of the samples. When
viscoelasticity is measured after a strong mechanical shock, the elastic
modulus G’ is completely recovered in less than 2 minutes only in
HYADD4. Synvisc and Durolane lose about 30% of their initial elastic
properties, most probably due to the partial cleavage of the chemical
crosslinks of the network. This tendency is conﬁrmed by the analogous
measurement after repeated mechanical stresses, where HYADD4 shows
a constant recovery of elasticity whilst the performance of Synvisc and
Durolane is progressively impaired. Furthermore, HYADD4 shows
a stronger resistance to stress than the two crosslinked HAs, proved by the
constancy of viscoelastic moduli in response to higher forces, probably due
to its less rigid structure.
Conclusions: Although Durolane, due to its more solid-like behavior, is
characterized by a higher viscosity and viscoelasticity than Synvisc and
the HYADD4 hydrogel, HYADD4 shows more favorable features than
both crosslinked HA-based hydrogels in stress-related tests. In fact in the
new hydrogel a strong resistance to stress and a self-healing mechanism
after disruption of the gel structure, given by mechanical shocks, have
been observed. This is very probably due to the chemical structure
differences between rigid crosslinked HAs (Synvisc and Durolane) and
the linear modiﬁcation of HA in HYADD4, that allows for formation of
reversible interactions yielding a gel-like structure. The unique rheological
features of HYADD4 could be potentially useful for the preservation of
viscosupplementation therapy effectiveness in time for active OA patients.
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EFFICACY AND SAFETY OF CONTINUOUS INTRA-ARTICULAR
HYALURONIC ACID INJECTION (HYALGAN) IN TREATMENT OF KNEE
OSTEOARTHRITIS PATIENTS WHO UNDERWENT HIGH TIBIAL
OSTEOTOMY, CLINICAL AND MRI EVALUATION
R. Narkbunnam, K. Chareancholvanich,
C. Pornrattanamaneewong. Mahidol Univ., Bangkok, Thailand
Purpose: Knee osteoarthritis is a disease of progression, causes by dete-
rioration of both mechanical and biochemical factors. High tibial osteot-
omy is one of standard surgical procedure to correct abnormal mechanical
load on the knee joint, whereas, intra-articular hyaluronic acid have
mechanism to restore viscoelastic property of synovial ﬂuid and balance
abnormal biochemical process. Theoretically, combination of these
modalities can create synergistic effect for treatment in knee osteoar-
thritis. This study aimed to evaluate the efﬁcacy and safety of continuous
intra-articular hyaluronic acid injection for treatment in osteoarthritis
knee patients who underwent high tibial osteotomy.
Methods: This study was designed as a randomized, controlled, observer
blinded study method. Forty patients with medial compartmental osteo-
arthritis knee were randomly assigned into control and study groups. The
study group (n¼20) received 2 cycles of 5 intra-articular injection with
sodium hyaluronate (Hyalgan) after high tibial osteotomy operation. The
control group (n¼20) did not receive any intra-articular injection. Treat-
ment efﬁcacies were evaluated by Western Ontario and McMaster
Universities (WOMAC) osteoarthritis index (at 6, 12, 24, 48 weeks after
